{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:18:26Z","timestamp":1783948706503,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejim.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T08:50:21Z","timestamp":1536828621000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment"],"prefix":"10.1016","volume":"59","author":[{"given":"Federica","family":"Depetri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-0763","authenticated-orcid":false,"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.09.004_bb0005","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/joim.12304","article-title":"Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients","volume":"277","author":"Mansi","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2017 revision and update","author":"Maurer","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.ejim.2018.09.004_bb0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology). Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.ejim.2018.09.004_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13601-017-0164-9","article-title":"Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials","volume":"317","author":"Bucher","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.ejim.2018.09.004_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cea.12869","article-title":"Bradykinin in idiopathic non-histaminergic angioedema","volume":"47","author":"Cugno","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ejim.2018.09.004_bb0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2018.09.004_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2018.09.004_bb0045","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.12648","article-title":"Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations","volume":"70","author":"Bork","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.ejim.2018.09.004_bb0050","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","article-title":"Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema","volume":"141","author":"Bafunno","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/all.13270","article-title":"Hereditary angioedema with a mutation in the plasminogen gene","volume":"73","author":"Bork","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.ejim.2018.09.004_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WOX.0b013e31817aecbe","volume":"1","author":"Kaplan","year":"2008","journal-title":"Angioedema World Allergy Organ J"},{"key":"10.1016\/j.ejim.2018.09.004_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.iac.2017.03.001","article-title":"Histaminergic Angioedema","volume":"37","author":"Busse","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ejim.2018.09.004_bb0070","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0075","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2018.09.004_bb0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1567-5769(02)00162-5","article-title":"Bradykinin and the pathophysiology of angioedema","volume":"3","author":"Cugno","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11739-013-0993-z","article-title":"Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts","volume":"9","author":"Cicardi","year":"2014","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12245-017-0141-z","article-title":"Angioedema in the emergency department: a practical guide to differential diagnosis and management","volume":"10","author":"Bernstein","year":"2017","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1378\/chest.128.2.976","article-title":"Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnaire survey in different medical categories","volume":"128","author":"Lombardi","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2018.09.004_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.autrev.2008.05.003","article-title":"Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation","volume":"8","author":"Cugno","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2018.09.004_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.critrevonc.2013.02.004","article-title":"Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship","volume":"87","author":"Castelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2017.04.006","article-title":"Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema","volume":"37","author":"Stone","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ejim.2018.09.004_bb0125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jch.13097","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature","volume":"19","author":"Brown","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ejim.2018.09.004_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","article-title":"Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema","volume":"60","author":"Brown","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejim.2018.09.004_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2753.2003.00484.x","article-title":"An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors","volume":"10","author":"Morimoto","year":"2004","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.ejim.2018.09.004_bb0140","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","article-title":"Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors","volume":"51","author":"Miller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2018.09.004_bb0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12016-016-8541-z","article-title":"Angioedema Phenotypes: Disease Expression and Classification","volume":"51","author":"Wu","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10875-016-0345-7","article-title":"Idiopathic Non-histaminergic Angioedema: successful Treatment with Omalizumab in five patients","volume":"37","author":"Faisant","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0155","first-page":"520","article-title":"Nonhistaminergic idiopathic angioedema: clinical response to icatibant","volume":"22","author":"Col\u00e1s","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0160","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaip.2014.05.006","article-title":"Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement","volume":"2","author":"Stahl","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ejim.2018.09.004_bb0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acem.12341","article-title":"American College of Allergy, Asthma & Immunology (ACAAI); Society for Academic Emergency Medicine (SAEM). A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman","year":"2014","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0170","first-page":"153","article-title":"Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema","volume":"136","author":"Sabroe","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0175","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice. Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000445835","article-title":"How not to be Misled by Disorders Mimicking Angioedema: a Review of Pseudoangioedema","volume":"169","author":"Andersen","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0185","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0091-6749(74)90119-5","article-title":"Erythema marginatum preceding hereditary angioedema","volume":"53","author":"Starr","year":"1974","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.iac.2017.04.007","article-title":"The Clinical Evaluation of Angioedema","volume":"37","author":"Gill","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ejim.2018.09.004_bb0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0194-5998(99)70182-8","article-title":"Predicting airway risk in angioedema: staging system based on presentation","volume":"121","author":"Ishoo","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ejim.2018.09.004_bb0200","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1312524","article-title":"Icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Ba\u015f","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.annemergmed.2010.03.032","article-title":"Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series","volume":"56","author":"Bas","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0210","first-page":"L645","article-title":"Stimulation of bovine pulmonary artery endothelial cell ACE by dexamethasone: involvement of steroid receptors","volume":"263","author":"Dasarathy","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0215","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mai.2002.121313","article-title":"Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema","volume":"109","author":"Karim","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0220","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1081-1206(10)61766-8","article-title":"Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema","volume":"92","author":"Warrier","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0225","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jemermed.2012.07.055","article-title":"Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema","volume":"44","author":"Hassen","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0230","doi-asserted-by":"crossref","first-page":"192.e1","DOI":"10.1016\/j.ajem.2016.06.089","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema worsened with fresh frozen plasma","volume":"35","author":"Adebayo","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2016.09.051","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","volume":"140","author":"Straka","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0240","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"Nothaft W; CAMEO study group. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema","volume":"5","author":"Sinert","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ejim.2018.09.004_bb0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annemergmed.2014.07.014","article-title":"Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial","volume":"65","author":"Lewis","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ejim.2018.09.004_bb0250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ejim.2018.09.004_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-6576.2005.00819.x","article-title":"Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate","volume":"50","author":"Nielsen","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ejim.2018.09.004_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200652","article-title":"ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate","author":"Rasmussen","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ejim.2018.09.004_bb0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ccr3.171","article-title":"Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert\u00ae): about one case and review of the therapeutic arsenal","volume":"3","author":"Lipski","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ejim.2018.09.004_bb0270","doi-asserted-by":"crossref","first-page":"E198","DOI":"10.1002\/lary.25113","article-title":"Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema","volume":"125","author":"Greve","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejim.2018.09.004_bb0275","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaip.2014.09.001","article-title":"Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks","volume":"3","author":"Craig","year":"2015","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518303650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518303650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:28:57Z","timestamp":1760606937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518303650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":55,"alternative-id":["S0953620518303650"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.09.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}